Fujifilm starts phase II clinical trial of Avigan for COVID-19 patients in the U.S.
TOKYO — Fujifilm announced the initiation of a U.S. phase II clinical trial to evaluate the safety and efficacy of its influenza antiviral drug “Avigan Tablet” for patients with COVID-19, a respiratory infection caused by the novel SARS-CoV-2 coronavirus. Avigan, approved in Japan for manufacture and sale as an influenza antiviral drug, selectively inhibits RNA polymerase necessary for
